Volume 24, Number 3—March 2018
Dispatch
Molecular and Epidemiologic Analysis of Reemergent Salmonella enterica Serovar Napoli, Italy, 2011–2015
Michela Sabbatucci
, Anna Maria Dionisi, Patrizio Pezzotti, Claudia Lucarelli, Lisa Barco, Marzia Mancin, and Ida Luzzi
, Anna Maria Dionisi, Patrizio Pezzotti, Claudia Lucarelli, Lisa Barco, Marzia Mancin, and Ida Luzzi
Table 1
Characteristics of patients infected with Salmonella enterica serovar Napoli and patients infected with the 5 most common other nontyphoidal serovars, Italy, 2011–2015*
| Characteristic |
Serovar Napoli, no. (%) |
Other serovars, no. (%) |
Total |
p value |
aOR (95% CI) |
|---|---|---|---|---|---|
| Sex | |||||
| M | 525 (5.2) | 7,470 (73.8) | 10,119 | 0.001 | 1.17 (1.02–1.35) |
| F | 383 (4.3) | 6,521 (73.5) | 8,876 | 1 | |
| Unknown |
111 (4.5) |
1,757 (70.5) |
2,491 |
0.94 (0.75–1.18) |
|
| Age, y | |||||
| <1 | 69 (8.8) | 491 (62.6) | 784 | <0.001 | 3.05 (2.22–4.18) |
| 1–14 | 584 (5.6) | 8,378 (80.2) | 10,442 | 1.57 (1.28–1.92) | |
| 15–64 | 127 (3.1) | 2,667 (65.6) | 4,063 | 1 | |
| >65 | 195 (5.0) | 2,447 (63.3) | 3,863 | 1.76 (1.39–2.22) | |
| Unknown |
44 (1.9) |
1,765 (75.6) |
2,334 |
0.65 (0.45–0.92) |
|
| Geographic area | |||||
| North | 893 (5.1) | 12,708 (73.0) | 17,397 | <0.001 | 1.77 (1.43–2.20) |
| Central | 102 (3.0) | 2,540 (74.1) | 3,428 | 1 | |
| South |
24 (3.6) |
500 (86.4) |
661 |
1.63 (1.02–2.61) |
|
| Time of sampling | |||||
| Jan–Mar | 12 (0.3) | 3,623 (78.3) | 4,626 | <0.001 | 1 |
| Apr–Jun | 203 (4.4) | 3,356 (73.2) | 4,584 | 17.98 (10.02–32.26) | |
| Jul–Sep | 594 (8.8) | 4,622 (68.5) | 6,752 | 38.00 (21.41–67.44) | |
| Oct–Dec |
210 (3.8) |
4,147 (75.1) |
5,524 |
15.15 (8.45–27.17) |
|
| Period of sampling | |||||
| 2011–2013 | 643 (4.3) | 11,152 (73.9) | 15,081 | <0.001 | 1 |
| 2014–2015 |
376 (5.9) |
4,596 (71.8) |
6,405 |
1.4 (1.22–1.61) |
|
| Hospitalization | |||||
| Yes | 368 (4.9) | 5,453 (72.4) | 7,533 | 0.583 | ND |
| No | 358 (4.9) | 5,533 (75.1) | 7,367 | ND | |
| Unknown |
293 (4.4) |
4,762 (72.3) |
6,586 |
ND |
|
| Bacteremia | |||||
| Yes | 962 (4.6) | 15,527 (74.1) | 20,962 | <0.001 | ND |
| No | 57 (10.9) | 221 (42.2) | 524 | ND | |
| Unknown |
6 (4.9) |
75 (61.0) |
123 |
ND |
|
| Total | 1,019 (4.7) | 15,748 (73.3) | 21,486 | ND | ND |
*The 5 most common other serovars were the monophasic variant of Typhimurium, Typhimurium, Derby, Enteritidis, and Infantis. Hospitalization and bacteremia were not included in evaluation of risk factors because they were considered a consequence of the infection, rather than risk factors. aOR, adjusted odds ratio; ND, not determined.
Page created: March 05, 2018
Page updated: March 05, 2018
Page reviewed: March 05, 2018
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.